Leadership Overview
WuXi AppTec has 7 executives leading key functions including corporate strategy, global operations, financial management, and strategic project development.
Committed to accelerating drug discovery through an open-access platform, WuXi AppTec empowers global partners to bring innovative therapies to patients by providing comprehensive research and manufacturing services across the entire pharmaceutical development lifecycle.
Committed to accelerating drug discovery through an open-access platform, WuXi AppTec empowers global partners to bring innovative therapies to patients by providing comprehensive research and manufacturing services across the entire pharmaceutical development lifecycle.
Leadership Roles at WuXi AppTec
Ge Li - Chief Executive Officer
Ge Li, the Chief Executive Officer at WuXi AppTec, directs the overarching corporate strategy and long-term vision for the global research and manufacturing platform. By fostering an open-access ecosystem, the Chief Executive Officer enables pharmaceutical and biotech companies to accelerate the discovery of small molecule drugs and advanced therapies. Ge Li maintains rigorous oversight of the six core business segments, ensuring that the organization remains at the forefront of synthetic molecular modalities. This leadership role involves constant engagement with the Board to align operational capabilities with international market demands. Through the promotion of integrated project solutions, the Chief Executive Officer drives the company toward its mission of making drug development more efficient. Ultimately, the strategic direction provided by Li ensures that the firm remains a critical partner for innovators across the People's Republic of China, the United States, and Europe.
Minzhang Chen - Co-Chief Executive Officer of WuXi AppTec
Minzhang Chen, the Co-Chief Executive Officer of WuXi AppTec at WuXi AppTec, manages the complex manufacturing and development operations that support global drug commercialization. Focusing on the WuXi Chemistry segment, the Co-Chief Executive Officer of WuXi AppTec optimizes synthetic processes for oligonucleotides, peptides, and complex conjugates. Minzhang Chen coordinates with internal research teams to ensure seamless transitions from candidate selection to large-scale clinical production. This role requires deep technical expertise to maintain high quality standards across international facilities. By streamlining manufacturing workflows, the Co-Chief Executive Officer of WuXi AppTec enhances the speed-to-market for critical therapeutic assets. Chen also collaborates with other C-suite leaders to align operational capacity with the evolving needs of the global pharmaceutical industry. Through this focused leadership, the firm achieves consistent growth in its contract development and manufacturing organization services, providing essential support for diverse molecular modalities.
Steve Yang - Co-Chief Executive Officer
Steve Yang, the Co-Chief Executive Officer at WuXi AppTec, oversees the biology services and integrated project solutions that span from target discovery to clinical entry. The Co-Chief Executive Officer directs the expansion of the WuXi Biology and WuXi DDSU segments, ensuring that research capabilities meet the sophisticated requirements of modern drug development. Steve Yang manages the strategic integration of stand-alone projects into the broader company platform, facilitating a cohesive approach to candidate selection. This leadership position involves constant interaction with global research partners to identify emerging trends in advanced therapies. By optimizing the research pipeline, the Co-Chief Executive Officer improves the efficiency of early-stage drug discovery. Yang also works closely with the executive team to ensure that scientific advancements translate into tangible business outcomes. Through this focus on innovation, the firm maintains a competitive edge in the international market, supporting the development of life-saving treatments for patients worldwide.
Florence Shi - Senior Vice President, Chief Financial Officer
Florence Shi, the Senior Vice President, Chief Financial Officer at WuXi AppTec, directs the financial strategy, capital allocation, and fiscal reporting for the entire organization. The Senior Vice President, Chief Financial Officer manages the financial health of the six business segments, ensuring that resources are effectively deployed to support research and manufacturing growth. Florence Shi oversees investor relations and ensures transparency in all financial disclosures to stakeholders. This role involves rigorous analysis of market trends to inform long-term investment decisions and risk management strategies. By maintaining a robust financial framework, the Senior Vice President, Chief Financial Officer supports the company's ability to scale its global operations and invest in advanced therapeutic technologies. Shi also works closely with the executive team to ensure that financial performance aligns with the overarching mission of the firm. Through this disciplined approach, the company secures the necessary capital to continue its expansion across international markets.
Zhaohui Zhang - Executive Vice President & Chief Operating Officer (China)
Zhaohui Zhang, the Executive Vice President & Chief Operating Officer (China) at WuXi AppTec, manages the daily operational execution and infrastructure development within the domestic market. The Executive Vice President & Chief Operating Officer (China) ensures that all laboratory and manufacturing facilities operate at peak efficiency to support the company's diverse service segments. Zhaohui Zhang coordinates cross-functional teams to maintain high standards of service delivery for clients across the People's Republic of China. This role involves overseeing resource allocation and process optimization to support the rapid scaling of research projects. By driving operational excellence, the Executive Vice President & Chief Operating Officer (China) enables the firm to meet the complex demands of drug discovery and development. Zhang also collaborates with regional leadership to ensure that domestic operations remain aligned with the global strategic goals of the organization. Through this focus on operational stability, the firm sustains its position as a leader in the regional pharmaceutical services sector.
Erich Koch - Chief Operations Officer
Erich Koch, the Chief Operations Officer at WuXi AppTec, manages the global operational infrastructure and supply chain logistics that underpin the company's service delivery. The Chief Operations Officer ensures that the international network of facilities maintains consistent quality and compliance standards across all regions. Erich Koch coordinates the integration of operational workflows to support the WuXi Testing and WuXi ATU segments. This role involves optimizing cross-border logistics to facilitate the seamless movement of research materials and clinical samples. By enhancing operational agility, the Chief Operations Officer enables the firm to respond rapidly to the needs of global pharmaceutical partners. Koch also collaborates with regional operations leaders to ensure that the company's service capacity scales in line with market demand. Through this focus on operational efficiency, the firm maintains its reputation for reliability and excellence in the international drug development landscape, supporting complex projects from discovery to commercialization.
Xiaozhong Liu - Executive VP & Head of the Strategic Project Office
Xiaozhong Liu, the Executive VP & Head of the Strategic Project Office at WuXi AppTec, directs the planning and execution of high-priority initiatives that drive the company's long-term growth. The Executive VP & Head of the Strategic Project Office manages the cross-segment coordination required to launch new service offerings and expand into emerging therapeutic areas. Xiaozhong Liu oversees the implementation of complex projects that require alignment across the WuXi Chemistry, Biology, and Testing divisions. This role involves identifying strategic opportunities for business development and ensuring that internal resources are focused on the most impactful initiatives. By managing the strategic project pipeline, the Executive VP & Head of the Strategic Project Office ensures that the firm remains adaptable to the rapidly changing pharmaceutical environment. Liu also works with the executive team to evaluate the feasibility of new market entries and service expansions. Through this leadership, the company successfully executes its vision for continuous innovation and market leadership.
Explore Leadership Teams in Business Services
AXISCADES is a leading product engineering solutions company catering to the futuristic needs of aerospace, defence, heavy engineering, automotive, energy, medical & healthcare sectors. Headquartered in Bengalore
Company Leadership PS
OFFICIAL PAGE - Renault Nissan Technology & Business Centre India (RNTBCI) is a captive automotive technology and business centre supporting Renault & Nissan globally. Established in 2007, it is located in Mahindra World City, Chennai, India, and the company's satellite offices are there in Hyderabad and Bengaluru. RNTBCI was bestowed with the ISO 9001:2015 certification in 2019 and ISO/IEC 27001:2013 certification in 2020 and is also now a Google Cloud Partner. RNTBCI contributes to Technology requirements with dedicated teams for Product Engineering: Vehicle and Components, Chassis, Powertrain, Embedded Software, Electrical and Electronic, Customer Performance, CAE and Test; Process Engineering: BIW, Trims, Stamping, Powertrain; Research and advanced Engineering: System Development, Battery Research, Social Research, and Creative Lab. RNTBCI has After-Sales Engineering, in-house Styling, and Test Capabilities for Multi-media/ EE Systems, Test Tracks, Test Chambers, and partnerships with various test agencies. RNTBCI also contributes to Business requirements in areas of IS/IT; APO; ACO and Global Shared Services (Finance, HR, GTC). As RNTBCI is serving both Renault and Nissan many of the Alliance practices are embodied in the company's way of working. RNTBCI is proud to be recognized by some of the important and influential organizations around the world. RNTBCI was felicitated as the ‘Best Employer of Tamil Nadu’ at the Tamil Nadu Best Employer Brand Awards 2022. For the fifth consecutive time, RNTBCI has been listed in the Top 100 Best Companies for Working Women by BCWI Study in 2022. RNTBCI has been commended time and again for CSR initiatives. The Indo-French Chamber of Commerce and Industry lauded RNTBCI’s CSR measures in 2021 and 2022. The Greater Chennai Corporation acknowledged and felicitated RNTBCI for CSR projects and support extended to the community during the COVID-19 pandemic.
Company Leadership CC
ST
PN
EA
LabConnect provides global central laboratory and client-inspired support services for logistically and analytically complex studies, routine testing, kit building, sample management and tracking, data management, biorepository and scientific functional outsourcing for biopharmaceutical and CRO clients. It offers a complete range of innovative project and data management services that connect high-quality samples to accurate data-and that can be customized to meet the unique needs of clients and their clinical studies. LabConnect's unique combination of state-of-the-art technology, world-class laboratories, and easy access to major and emerging markets means that drug development companies can rely on one preeminent provider for their central laboratory and preclinical through Phase IV clinical development needs.
Company Leadership RH
RL
)
Nuziveedu Seeds Limited (NSL) is a prominent seed company in India, recognized for its excellence in research and development. The company specializes in breeding programs that genetically enhance crops, focusing on field crops, fiber crops, and vegetable crops. With a commitment to quality and innovation, NSL supports farmer productivity through advanced seed technology and extensive processing facilities. NSL serves millions of farmers across South Asia, positioning itself as a trusted ally in agriculture.
Company Leadership AS
KA
SA
SV
Frequently Asked Questions Regarding WuXi AppTec Top Executives and Leadership Team
